Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Shusuan Jiang"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract Prostate cancer, one of the most prevalent malignancies among men worldwide, is intricately linked with androgen signaling, a key driver of its pathogenesis and progression. Understanding the diverse expression patterns of androgen-responsiv
Externí odkaz:
https://doaj.org/article/c5724a87979a4aa0bf83399000dead6c
Autor:
Wei Ouyang, Ran Xu, Hanyu Yao, Shusuan Jiang, Qiang Lu, Cai Lv, Pei Li, Genming Xu, Jianye Liu, Long Wang
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 1, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/a76d5caaadcd467a8519dd09d206c607
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectivesStandard magnetic resonance imaging (MRI) techniques are different to distinguish minimal fat angiomyolipoma (mf-AML) with minimal fat from renal cell carcinoma (RCC). Here we aimed to evaluate the diagnostic performance of MRI-based radiom
Externí odkaz:
https://doaj.org/article/30d0e3006d83451387c2bb4927773908
Publikováno v:
Frontiers in Molecular Biosciences, Vol 9 (2022)
Objective: Accumulated evidence demonstrates that ageing is a robust risk factor of prostate cancer prognosis. Herein, we conducted a systematic analysis about ageing-relevant molecules and relevant tumor microenvironment features in prostate cancer.
Externí odkaz:
https://doaj.org/article/a3686ce00f074fbe8ca4408ac3e11858
Publikováno v:
Journal of Immunology Research, Vol 2022 (2022)
Clear cell renal cell carcinoma (ccRCC) was a common cancer type diagnosed with frequent metastases, harboring an unfavorable therapeutic response, and results in a poor prognosis. More promising therapeutic targets are urgently required for treating
Externí odkaz:
https://doaj.org/article/139708a3fbab409ab4c2c39cc8191acf
Autor:
Senlin Ye, Haohui Wang, Kancheng He, Mou Peng, Yinhuai Wang, Yuanwei Li, Shusuan Jiang, Jin Li, Lu Yi, Rongrong Cui
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Mismatch repair-deficient (dMMR) prostate cancer is rare and has not been well studied. We aimed to evaluate the clinical characterization of dMMR metastatic castration-resistant prostate cancer (mCRPC) patients. The MMR genes include MLH1, MLH3, MSH
Externí odkaz:
https://doaj.org/article/43364a294adc4dcd80cd31ff04dc0679
Autor:
Sulai Liu, Lin Qi, Weiqing Han, Xinxing Wan, Shusuan Jiang, Yuan Li, Yu Xie, Longfei Liu, Fuhua Zeng, Zhizhong Liu, Xiongbing Zu
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e110218 (2014)
Wild-type p53-induced phosphatase (Wip1 or PPM1D) has been reported to be aberrantly expressed in various cancers and correlated with the malignant behavior of cancer cells. However, the function of Wip1 in RCC remains unclear. The present study inve
Externí odkaz:
https://doaj.org/article/e3594410b9a941c193ec1e80b4ab9ca4
Autor:
Tao Dai, Zhenzhou Xu, Liang Huang, Yike Wang, Gongqian Zeng, Mingji Ye, Kan Liu, Fuhua Zeng, Shusuan Jiang, Weiqing Han, Jingying Cao
Publikováno v:
British journal of clinical pharmacologyREFERENCES.
To evaluate the pharmacokinetic effects of SHR3680 on repaglinide and bupropion and its metabolite hydroxybupropion.A single-centre, open-label, single-arm, fixed-sequence clinical trial in 18 patients with prostate cancer.After a single oral dose of
Autor:
Mingji Ye, Shusuan Jiang, Zhenzhou Xu, Gongqian Zeng, Liang Huang, Xiaming Pei, Weiqing Han, Fuhua Zeng, Longzheng Xia, Kan Liu, Tao Dai
Publikováno v:
OncoTargets and therapy
Zhenzhou Xu,* Liang Huang,* Tao Dai,* Xiaming Pei, Longzheng Xia, Gongqian Zeng, Mingji Ye, Kan Liu, Fuhua Zeng, Weiqing Han, Shusuan Jiang Department of Urology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South
Autor:
Xiaming Pei, Xiaoxiao Hu, Zhenzhou Xu, Kan Liu, Shusuan Jiang, Zhizhong Liu, Yu Xie, Weiqing Han
Publikováno v:
Evidence-Based Complementary and Alternative Medicine.
Renal cell carcinoma is abbreviated as renal carcinoma, and its clinical symptoms are basically hematuria, lumbago, and abdomen bump. As people’s lifestyles change, the incidence of renal carcinoma continues to rise due to factors such as smoking a